2008: 99/3 (Mar) pp. 457-645

Journal:Thrombosis and Haemostasis
ISSN:0340-6245

Archive
Issue

31 articles
1.
A renaissance for the contact system in blood coagulation?

Yuval Blat1, Dietmar Seiffert2

1Department of Chemical Enzymology and 2Department of Thrombosis Biology, Bristol-Myers Squibb Company, Pennington, New Jersey, USA

Thrombosis and Haemostasis 2008 99 3: 457-460

http://dx.doi.org/10.1160/TH07-11-0692

[Summary] [Free download]
2.
Perplexity of monocyte responses to C-reactive protein (CRP)

János G. Filep

Research Center, Maisonneuve-Rosemont Hospital, University of Montreal, Montral, Quebec, Canada

Thrombosis and Haemostasis 2008 99 3: 461-462

http://dx.doi.org/10.1160/TH08-02-0072

[Summary] [Free download]
3.
A long-awaited small step forward in the management of the post-thrombotic syndrome

Marcel Levi

Department of Vascular Medicine and Internal Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

Thrombosis and Haemostasis 2008 99 3: 463-464

http://dx.doi.org/10.1160/TH08-01-0055

[Summary] [Free download]
4.
From Molecules to Medicine: New Horizons in Vascular Biology and Thrombosis (Part II)

Klaus T. Preissner

Institute for Biochemistry, Medical School, Justus-Liebig-University, Giessen, Germany

Thrombosis and Haemostasis 2008 99 3: 465-465

http://dx.doi.org/10.1160/TH08-02-0070

[Summary] [Free download]
5.
P2 receptors, platelet function and pharmacological implications

Christian Gachet

Institut National de la Santé et de la Recherche Médicale, U311, Strasbourg, France; Etablissement Français du Sang-Alsace, Strasbourg, France; Université Louis Pasteur, Strasbourg, France

Thrombosis and Haemostasis 2008 99 3: 466-472

http://dx.doi.org/10.1160/TH07-11-0673

[Summary] [Free download]
6.
Platelet GPIb complex as a target for anti-thrombotic drug development

Kenneth J. Clemetson, Jeannine M. Clemetson

Theodor Kocher Institute, University of Berne, Berne, Switzerland

Thrombosis and Haemostasis 2008 99 3: 473-479

http://dx.doi.org/10.1160/TH07-12-0718

[Summary] [Free download]
7.
Platelet-vessel wall interactions in atherosclerotic disease

Harald F. Langer*, Meinrad Gawaz

Medizinische Klinik III, Klinik für Kardiologie und Kreislauferkrankungen, Eberhard Karls-Universität Tübingen, Tübingen, Germany; *Currently: Experimental Immunology Branch, National Cancer Institute, NIH, Bethesda, Maryland, USA

Thrombosis and Haemostasis 2008 99 3: 480-486

http://dx.doi.org/10.1160/TH07-11-0685

[Summary] [Free download]
8.
Individualized antithrombotic therapy in high risk patients after coronary stenting. A double-edged sword between thrombosis and bleeding

Andreas E. May, Tobias Geisler, Meinrad Gawaz

Medizinische Klinik III (Kardiologie und Kreislauferkrankungen), Eberhard Karls Universität, Tübingen, Germany

Thrombosis and Haemostasis 2008 99 3: 487-493

http://dx.doi.org/10.1160/TH07-11-0680

[Summary] [Free download]
9.
Current view on alveolar coagulation and fibrinolysis in acute inflammatory and chronic interstitial lung diseases

Malgorzata Wygrecka1, Ewa Jablonska1, Andreas Guenther2, Klaus T. Preissner1, Philipp Markart2

Departments of 1Biochemistry, and 2Internal Medicine, Faculty of Medicine, University of Giessen Lung Center, Giessen, Germany

Thrombosis and Haemostasis 2008 99 3: 494-501

http://dx.doi.org/10.1160/TH07-11-0666

[Summary] [Free download]
10.
[Add to basket]
Treatment of pulmonary embolism: The use of low-molecularweight heparin in the inpatient and outpatient settings

Russell D. Hull

Thrombosis and Haemostasis 2008 99 3: 502-510

http://dx.doi.org/10.1160/TH07-08-0500

[Summary] [PDF] [Pay per view]
11.
[Add to basket]
The interaction of fragment 1 of prothrombin with the membrane surface is a prerequisite for optimum expression of factor Va cofactor activity within prothrombinase

Michael A. Bukys1, Tivadar Orban1, Paul Y. Kim2, Michael E. Nesheim2,3, Michael Kalafatis1,4

1Department of Chemistry, Cleveland State University, Cleveland, Ohio, USA; Departments of 2Biochemistry and 3Medicine, Queen’s University, Kingston, Ontario, Canada; 4Department of Molecular Cardiology, Lerner Research Institute, The Cleveland Clinic, Cleveland, Ohio, USA

Thrombosis and Haemostasis 2008 99 3: 511-522

http://dx.doi.org/10.1160/TH07-08-0532

[Summary] [PDF] [Pay per view]
12.
[Add to basket]
Molecular characterization of two novel mutations causing factor XI deficiency: A splicing defect and a missense mutation responsible for a CRM+ defect

Ilaria Guella1, Giulia Soldà1, Silvia Spena1, Rosanna Asselta1, Rossella Ghiotto2, Maria Luisa Tenchini1, Giancarlo Castaman2, Stefano Duga1

1Department of Biology and Genetics for Medical Sciences, University of Milan, Milan, Italy; 2Department of Hematology and Hemophilia and Thrombosis Center, San Bortolo Hospital, Vicenza, Italy

Thrombosis and Haemostasis 2008 99 3: 523-530

http://dx.doi.org/10.1160/TH07-12-0723

[Summary] [PDF] [Pay per view]
13.
[Add to basket]
An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases

Fábio R. Melo, Paulo A. S. Mourão

Laboratório de Tecido Conjuntivo, Hospital Universitário Clementino Fraga Filho and Programa de Glicobiologia, Instituto de Bioquímica Médica, Centro de Ciências da Saúde, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

Thrombosis and Haemostasis 2008 99 3: 531-538

http://dx.doi.org/10.1160/TH07-10-0649

[Summary] [PDF] [Pay per view]
14.
[Add to basket]
Slight differences in sulfation of algal galactans account for differences in their anticoagulant and venous antithrombotic activities

Roberto J. C. Fonseca1, Stephan-Nicollas M. C. G. Oliveira1, Fábio R. Melo1, Maria G. Pereira2, Norma M. B. Benevides2, Paulo A. S. Mourão1

1Laboratório de Tecido Conjuntivo, Hospital Universitário Clementino Fraga Filho and Programa de Glicobiologia, Instituto de Bioquímica Médica, Centro de Ciências da Saúde, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil; 2Departamento de Bioquímica e Biologia Molecular, Universidade Federal do Ceará, Fortaleza, Ceará, Brazil

Thrombosis and Haemostasis 2008 99 3: 539-545

http://dx.doi.org/10.1160/TH07-10-0603

[Summary] [PDF] [Pay per view]
15.
[Add to basket]
Clinical presentation and time-course of postoperative venous thromboembolism: Results from the RIETE Registry

Juan Ignacio Arcelus1, Manuel Monreal2, Joseph A. Caprini3, Javier Gutiérrez Guisado4, Mª José Soto5, Manuel Jesús Núñez6, Juan Carlos Alvárez7, and the RIETE investigators

1Departamento de Cirugía de la Universidad de Granada y Hospital Virgen de las Nieves, Granada, Spain; 2Servicio de Medicina Interna, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; 3Department of Surgery, Evanston Northwestern Healthcare, Evanston, Illinois, USA; 4Servicio de Medicina Interna, Hospital Asepeyo Coslada, Madrid, Spain; 5Servicio de Medicina Interna, Hospital Universitario Puerta del Mar, Cádiz, Spain; 6Servicio de Medicina Interna, Hospital Comarcal de Salnés, Pontevedra, Spain; 7Servicio de Medicina Interna, Hospital Virgen de Macarena, Sevilla, Spain; and the RIETE Investigators*

Thrombosis and Haemostasis 2008 99 3: 546-551

http://dx.doi.org/10.1160/TH07-10-0611

[Summary] [PDF] [Pay per view]
16.
[Add to basket]
Effect of an anti-sulfatide single-chain antibody probe on platelet function

Prasenjit Guchhait1, Corie N. Shrimpton1, Koichi Honke2, Rolando E. Rumbaut3, Jose A. Lopez4, Perumal Thiagarajan1,3

1Thrombosis Research Section, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA; 2Department of Biochemistry, Kochi University Medical School, Kochi, Japan; 3Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA; 4Research Division, Puget Sound Blood Center, Seattle, Washington, USA

Thrombosis and Haemostasis 2008 99 3: 552-557

http://dx.doi.org/10.1160/TH07-05-0351

[Summary] [PDF] [Pay per view]
17.
[Add to basket]
C-reactive protein induces pro- and anti-inflammatory effects, including activation of the liver X receptor α, on human monocytes

Didier Hanriot1,2*, Gaëlle Bello1,2*, Armelle Ropars1,2, Carole Seguin-Devaux5, Gaël Poitevin1,2, Sandrine Grosjean3, Véronique Latger-Cannard2,3,4, Yvan Devaux1,2,5, Faiez Zannad1,2, Véronique Regnault2,4, Patrick Lacolley1,2, Paul-Michel Mertes1,2, Ketsia Hess*1,2, Dan Longrois*1,2

1INSERM, U684, Nancy, France; 2Henri Poincaré University, Nancy, France; 3CHU Nancy, Nancy, France; 4INSERM, U734, Nancy, France; 5CRP-Sante, Luxembourg Hospital, Luxembourg

Thrombosis and Haemostasis 2008 99 3: 558-569

http://dx.doi.org/10.1160/TH07-06-0410

[Summary] [PDF] [Pay per view]
18.
[Add to basket]
Concentration-dependent roles for heparin in modifying liopolysaccharide-induced activation of mononuclear cells in whole blood

Helene Hochart1, P. Vincent Jenkins1,2, Roger J. S. Preston1, Owen P. Smith3, Barry White1,2, James O’Donnell1,2

1Thrombosis and Haemostasis Research Group, Institute of Molecular Medicine, Trinity Centre for Health Sciences, Trinity College Dublin, 2National Centre for Hereditary Coagulation Disorders, St James's Hospital, Dublin, and 3 Department of Paediatric Haematology and Oncology, Our Lady’s Hospital for Sick Children, Dublin; Ireland

Thrombosis and Haemostasis 2008 99 3: 570-575

http://dx.doi.org/10.1160/TH07-06-0424

[Summary] [PDF] [Pay per view]
19.
[Add to basket]
Tissue factor pathway inhibitor (TFPI) interferes with endothelial cell migration by inhibition of both the Erk pathway and focal adhesion proteins

Mathieu Provençal1, Marisol Michaud1, Édith Beaulieu1, David Ratel1, Georges-Étienne Rivard2, Denis Gingras1, Richard Béliveau1,2

1Laboratoire de médecine moléculaire, Hôpital Ste-Justine-UQAM, Centre de cancérologie Charles-Bruneau, Centre de Recherche de l’Hôpital Sainte-Justine, Chemin Côte-Sainte-Catherine, Montréal, Québec, Canada; 2Service d'Hématologie-Oncologie, Hôpital Ste-Justine, Montréal, Québec, Canada

Thrombosis and Haemostasis 2008 99 3: 576-585

http://dx.doi.org/10.1160/TH07-10-0623

[Summary] [PDF] [Pay per view]
20.
[Add to basket]
Magnesium maintains endothelial integrity, up-regulates proteolysis of ultra-large von Willebrand factor, and reduces platelet aggregation under flow conditions

Jing-fei Dong1,2*, Miguel A. Cruz1, Khatira Aboulfatova1, Cecilia Martin1, Hiuwan Choi1, Angela L. Bergeron1, Sheryl R. Martini3, Michael H. Kroll1,2, Thomas A. Kent3

1Section of Thrombosis Research, 2Section of Hematology/Oncology, Department of Medicine, and 3Department of Neurology, Baylor College of Medicine and the Michael E. DeBakey VA Medical Center Stroke Program, Houston, Texas, USA

Thrombosis and Haemostasis 2008 99 3: 586-593

http://dx.doi.org/10.1160/TH07-11-0694

[Summary] [PDF] [Pay per view]
  1-20 21-31
Next page

Articles

You've 276 Article(s) in your Basket.

Thrombosis News

TH 107.5

Clinical Focus on GPIIb/IIIa inhibitors: In the May issue of Thrombosis and Haemostasis Armstrong...

TH 107.4

The April 2012 issue of Thrombosis and Haemostasis TH 107.4 is a Theme Issue by A. Schober, T....

Thrombosis and Haemostasis official organ of Spanish Society for Thrombosis and Haemostasis

Thrombosis and Haemostasis, founded in 1957, has become the official organ of the Spanish Society...